EUVIMEDEUVIMED entdecken
Crossref

Chronic cholestatic liver disease impairs skeletal muscle regeneration: partial modulation by ursodeoxycholic acid of satellite cells and innate immunity

Eduardo Cifuentes-Silva, Franco Tacchi, Marianny Portal-Rodríguez, María Cristina Miranda-Pilar, Javier Salgado-Valdovinos, Jorge A Soto, Claudio Cabello-Verrugio iD

Molecular Biology Reports · 2026-12 · 53 (1)

DOI: 10.1007/s11033-026-13137-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Biology Reports, online erschienen am 12.11.2026. Verfasst von Eduardo Cifuentes-Silva und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Muscle Pathology, Fragility, and Aging, Faculty of Life Sciences, Universidad Andrés Bello, Santiago, Chile. Hauptthemen laut MEDLINE: Ursodeoxycholic Acid, Regeneration, Muscle, Skeletal, Satellite Cells, Skeletal Muscle. Die Arbeit nennt 50 Literaturangaben. Gefördert von: Agencia Nacional de Investigación y Desarrollo (ANID)/FONDECYT, Agencia Nacional de Investigación y Desarrollo (ANID)/FONDECYT Exploración.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Chronic cholestatic liver disease (CCLD) is associated with skeletal muscle dysfunction, but its effects on muscle regeneration and the response to ursodeoxycholic acid (UDCA) remain incompletely characterized. METHODS AND RESULTS: Male C57BL/6 mice received standard chow or a 0.1% 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) diet, with vehicle or UDCA (15 mg/kg/day); tibialis anterior cryoinjury at week 6 was followed by a 12-day recovery (n = 3-6 per group, depending on the assay). We assessed histology, fiber morphometry, embryonic myosin heavy chain (MyHC-emb) staining, flow cytometry, and adult MyHC isoforms. CCLD + UDCA exhibited more histologically altered tissue, more centrally nucleated fibers (both p < 0.0001), and more MyHC-emb⁺ fibers (p = 0.0002) than CCLD at day 12. The Pax7⁺ fraction was greater in CCLD than in controls (18.55% vs. 4.67%; adjusted p = 0.0001) and lower in CCLD + UDCA than in CCLD (4.63%; p = 0.0001), without a change in Myf5/MyoD composition within Pax7⁺ cells. CCLD + UDCA did not differ significantly from CCLD for MHC-II⁺, M1-like, or M2-like macrophage-associated frequencies, whereas the CD11b⁺Ly6G⁺ fraction was higher (p = 0.0043). MyHC-IIB abundance was greater in CCLD + UDCA than in CCLD (p = 0.0436). CONCLUSIONS: UDCA at 15 mg/kg/day altered selected myogenic and immune marker-defined readouts and MyHC-IIB abundance but did not improve histological indices of post-cryoinjury repair at day 12. A single endpoint cannot distinguish delayed progression, differences in initial injury burden, or persistently incomplete regeneration. These data do not support a clinical recommendation of UDCA for muscle repair.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ursodeoxycholic AcidRegenerationMuscle, SkeletalSatellite Cells, Skeletal MuscleImmunity, InnateCholestasisLiver DiseasesAnimalsMaleMiceMice, Inbred C57BLMyosin Heavy ChainsChronic Disease

Stichwörter der Autor:innen

CryoinjuryMacrophagesNeutrophilsPax7Satellite cellsSecondary sarcopenia

Substanzen

Ursodeoxycholic AcidMyosin Heavy Chains

Autor:innen und Institutionen

  • Laboratory of Muscle Pathology, Fragility, and Aging, Faculty of Life Sciences, Universidad Andrés Bello, Santiago, Chile.
  • Escuela de Kinesiología, Facultad de Ciencias de La Salud, Universidad Autónoma de Chile, Santiago, Chile.
  • Center for Research on Pandemic Resilience, Faculty of Life Sciences and Institute of Public Health, Universidad Andrés Bello, Santiago, Chile.
  • Laboratory of Virology and Integrative Translational Immunology, Faculty of Life Sciences, Universidad Andres Bello, Santiago, Chile.
  • Dirección de Investigación, Universidad de Talca, Talca, Chile. claudio.cabello.verrugio@gmail.com.

ORCID-Profile: Claudio Cabello-Verrugio

Förderung

  • Agencia Nacional de Investigación y Desarrollo (ANID)/FONDECYT
  • Agencia Nacional de Investigación y Desarrollo (ANID)/FONDECYT Exploración

Zitieren

APA

Cifuentes-Silva, E., Tacchi, F., Portal-Rodríguez, M., Miranda-Pilar, M. C., Salgado-Valdovinos, J., Soto, J. A., & Cabello-Verrugio, C. (2026). Chronic cholestatic liver disease impairs skeletal muscle regeneration: partial modulation by ursodeoxycholic acid of satellite cells and innate immunity. Molecular Biology Reports, 53(1). https://doi.org/10.1007/s11033-026-13137-3

Vancouver

Cifuentes-Silva E, Tacchi F, Portal-Rodríguez M, Miranda-Pilar MC, Salgado-Valdovinos J, Soto JA, et al. Chronic cholestatic liver disease impairs skeletal muscle regeneration: partial modulation by ursodeoxycholic acid of satellite cells and innate immunity. Molecular Biology Reports. 2026;53(1). doi:10.1007/s11033-026-13137-3

BibTeX
@article{CifuentesSilva2026,
  author = {Cifuentes-Silva, Eduardo and Tacchi, Franco and Portal-Rodríguez, Marianny and Miranda-Pilar, María Cristina and Salgado-Valdovinos, Javier and Soto, Jorge A and Cabello-Verrugio, Claudio},
  title = {Chronic cholestatic liver disease impairs skeletal muscle regeneration: partial modulation by ursodeoxycholic acid of satellite cells and innate immunity},
  journal = {Molecular Biology Reports},
  year = {2026},
  volume = {53},
  number = {1},
  doi = {10.1007/s11033-026-13137-3}
}
Kostenlos starten →